First Two United States Patients Receive CartiHeal’s Agili-C Implants
The Israeli startup develops implants to treat cartilage and osteochondral defects in traumatic and osteoarthritic joints; to date, 80 patients...
The Israeli startup develops implants to treat cartilage and osteochondral defects in traumatic and osteoarthritic joints; to date, 80 patients...
The company’s BKS features implants and instrumentation that address primary and revision procedures. A patented locking mechanism is designed to...
P-15L graft, a substitute for autologous bone, is based on synthetic small peptide technology and was developed to spur bone...
A review of patent activity in 1H18 shows technological innovations from companies like Episurf, iOrthopedics, Orthocell and Spineology across arthroscopy/soft...
Active Implants is pursuing an FDA De Novo 510(k) clearance for the device. If cleared, NUsurface would be the first...
To provide insight on new competitors entering the U.S. orthopaedic market, we offer details on five companies and their first...
Medical imaging diagnostic group Imagen Technologies created OsteoDetect software, which identifies fractures in x-rays using an AI algorithm to analyze...
These two developments could assist Paradigm Spine in adoption of its novel product that has faced reimbursement hurdles....
A smart legal strategy is to develop a comprehensive intellectual property portfolio of the various diverse–but related–IP rights associated with...
Elements of a well-constructed plan include an understanding of regulatory requirements, a comprehensive review of all documentation and a thorough...
Exactech’s FDA-cleared Equinoxe is competition for Wright Medical and Zimmer Biomet’s offerings. The three are the only FDA-cleared stemless shoulders...
Infection rates, regulatory implications and the efforts of hospitals to cut costs have driven sterilization changes in device packaging. ...
Primary total hip arthroplasty (THA) has undergone 25 years of product development, thanks to contributions from a host of materials...
The Stockholm, Sweden-based company is preparing a 2Q18 launch of patient-specific Episealer® implants to treat osteochondral lesions of the talus...
The initiative is designed to mitigate risk associated with readmissions in value-based healthcare reimbursement models....
Login
Login to your Bonezone account to access favorite articles, saved suppliers, and more.
Create an account
In less than a minute you'll have access to a customizable BONEZONE experience.
Password reset
We’ll send a recovery link to your email.